Yahoo Finance

Aphaia Pharma Publishes Phase 1 and 2 Clinical Data of Oral Formulation in Patients with Obesity and Prediabetes

ZUG, Switzerland and SAN JUAN, Puerto Rico, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage company developing precision-targeted drug formulations that harness endogenous ...
FiercePharma

Biodel's Glucagon Formulation for Use in a Proprietary Auto-Reconstitution Device for the Treatment of Severe Hypoglycemia Meets Primary Efficacy Endpoint in Phase 1 Clinical Trial

BIOD-961 Administration Results in Glucagon Exposure and Glucose Response That Meets Standard Bioequivalence Criteria When Compared to Marketed Glucagon; Conference Call and Webcast Will be Held on ...
FierceBiotech

NextPharma's Sterile Product Development Center in Belgium has Formulated Viscous, Lipid Based Formulation for Clinical Trials

NextPharma Technologies Announces that its Sterile Product Development Center in Belgium has been Successful in Formulating, Manufacturing and Labeling a Viscous, Lipid Based Formulation for Clinical ...
FiercePharma

Glide Appoints Albany Molecular Research for Manufacture of Novel Octreotide Solid Dose Formulation Clinical Trial Product

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today announced that it has appointed Albany Molecular ...